20 (AIDX) Other Non-Current Liabilities (2025 - 2026)
20's (AIDX) quarterly Other Non-Current Liabilities came in at $0.01 in Q1 2026, down 100.0% on a QoQ basis from $543545.0 in Q4 2025.
20 (AIDX) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Other Non-Current Liabilities data on file, last reported at $0.01 in Q1 2026.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.01 (changed N/A YoY) and the FY2025 annual result came in at $543545.0, changed N/A from the prior year.
- Other Non-Current Liabilities declined to $0.01 in Q1 2026, from $543545.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $543545.0 in Q4 2025 to a low of $0.01 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | 20 | 5.55 Mn | 1.00 Mn | 304,727.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 543,545.00 |